Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

5.49
Delayed Data
As of Oct 23
 -0.37 / -6.31%
Today’s Change
1.51
Today|||52-Week Range
8.84
+169.12%
Year-to-Date

Today’s Trading

Previous close5.86
Today’s open5.87
Day’s range5.47 - 6.01
Volume3,422,566
Average volume (3 months)3,696,167
Market cap$657.6M
Dividend yield--
Data as of 10/23/2017

Growth & Valuation

Earnings growth (last year)-154.93%
Earnings growth (this year)+50.82%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-49.72%
P/E ratioNM
Price/Sales4.13
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CHRSCoherus BioSciences ...-0.45-3.28%
NTLAIntellia Therapeutic...+1.03+3.65%
BOLDAudentes Therapeutic...+0.17+0.68%
AMAGAMAG Pharmaceuticals...+0.45+2.88%
Data as of 10/23/2017

Financials

Next reporting dateOctober 27, 2017
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$43.0M
Annual profit (last year)-$157.8M
Net profit margin-366.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts